Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 57, 2022 - Issue 4
Submit an article Journal homepage
745
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Dose–escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice

Tero Ylisaukko-ojaa MedEngine Oy, Helsinki, Finland;b Faculty of Medicine, Center for Life Course Health Research, University of Oulu, Oulu, FinlandCorrespondence[email protected]
View further author information
,
Minna Puttonenc Takeda Oy, Helsinki, Finland;d Division of Pharmaceutical Technology and Chemistry, Industrial Pharmacy, University of Helsinki, Helsinki, FinlandView further author information
,
Jari Jokelainena MedEngine Oy, Helsinki, Finland;b Faculty of Medicine, Center for Life Course Health Research, University of Oulu, Oulu, FinlandView further author information
,
Mirkka Koivusaloa MedEngine Oy, Helsinki, FinlandView further author information
,
Klaus Tamminenc Takeda Oy, Helsinki, FinlandView further author information
,
Saku Torvinenc Takeda Oy, Helsinki, FinlandView further author information
&
Markku Voutilainene Division of Medicine, Turku University Hospital, Turku, Finland;f Department of Medicine, University of Turku, Turku, FinlandView further author information
 show all
Pages 415-423 | Received 10 Aug 2021, Accepted 01 Dec 2021, Published online: 19 Dec 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Antonio Tursi, Giammarco Mocci, Angelo Del Gaudio & Alfredo Papa. (2024) Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies. Expert Opinion on Biological Therapy 24:3, pages 171-189.
Read now

Articles from other publishers (3)

Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale & Rupert W. Leong. (2024) Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics.
Crossref
Giammarco Mocci, Antonio Tursi, Francesca Maria Onidi, Paolo Usai-Satta, Giovanni Mario Pes & Maria Pina Dore. (2024) Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms. Journal of Clinical Medicine 13:5, pages 1519.
Crossref
Mathurin Fumery, Stéphane Nancey, Jérôme Filippi, Romain Altwegg, Xavier Hébuterne, Gilles Boshetti, Mathilde Barraud, Jonathan Meynier, Stéphane Paul & Xavier Roblin. (2023) Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study. Alimentary Pharmacology & Therapeutics 57:11, pages 1290-1298.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.